Analgesic benefits of pre-operative versus postoperative transversus abdominis plane block for laparoscopic cholecystectomy: a frequentist network meta-analysis of randomized controlled trials Authors: Burhan Dost, Alessandro De Cassai, Eleonora Balzani, Federico Geraldini, Serkan Tulgar, Ali Ahiskalioglu, Yunus Emre Karapinar, Müzeyyen Beldagli, Paolo Navalesi, Cengiz Kaya Published: 2023 ABSTRACT BackgroundTransversus abdominis plane (TAP) block has been utilized to alleviate pain following laparoscopic cholecystectomy (LC). However, the optimal timing of administration remains uncertain. This study aimed to compare the efficacy of pre-operative and postoperative TAP blocks as analgesic options after LC.MethodsA frequentist network meta-analysis of randomized controlled trials (RCTs) was conducted. We systematically searched PubMed (via the National Library of Medicine), EMBASE, Scopus, Cochrane Central Register of Controlled Trials (CENTRAL), and Web of Science up to March 2023. The study included RCTs that enrolled adult patients (≥ 18 years) who underwent LC and received either pre-operative or postoperative TAP blocks. The primary outcome assessed was 24-hour postoperative morphine consumption (mg). Additionally, pain rest scores within 3 hours, 12 hours, and 24 hours, as well as postoperative nausea and vomiting (PONV), were considered as pre-specified secondary outcomes.ResultsA total of 34 trials with 2317 patients were included in the analysis. Postoperative TAP block demonstrated superiority over the pre-operative TAP block in reducing opioid consumption (MD 2.02, 95% CI 0.87 to 3.18, I2 98.6%, p < 0.001). However, with regards to postoperative pain, neither pre-operative nor postoperative TAP blocks exhibited superiority over each other at any of the assessed time points. The postoperative TAP block consistently ranked as the best intervention using SUCRA analysis. Moreover, the postoperative TAP block led to the most significant reduction in PONV.ConclusionsThe findings suggest that the postoperative TAP block may be slightly more effective in reducing 24-hour postoperative opioid consumption and PONV when compared to the pre-operative TAP block.Trial registrationPROSPERO, CRD42023396880.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12871-023-02369-6. Introduction Laparoscopic cholecystectomy (LC) is considered a minimally invasive surgical procedure compared to traditional open cholecystectomy [1, 2]. However, although less severe in LC, procedure-related pain remains a problem that needs to be addressed by clinicians [1, 3]. Pharmacological treatments, such as nonsteroidal anti-inflammatory drugs and opioids, are frequently used in pain management in LC [4, 5]. Also, loco-regional anesthesia techniques, such as port site infiltration and fascial plane blocks, can improve the quality of pain management [3]. The transversus abdominis plane (TAP) block is one of the first fascial plane blocks for pain management after various surgical procedures, including laparoscopic surgeries. The TAP block aims to provide sensory blockage of the anterior abdominal wall and generally does not affect visceral pain [6, 7]. Numerous studies have been published on the peri-operative analgesic efficacy of TAP block types (because there is more than one approach) in LC [8–10]. In many studies on regional anesthesia, the aim was to measure the effectiveness of the blocks. In these studies, measurements are usually set up as parameters such as opioid requirement, pain scores, and healing quality scores at a specific time interval [7]. However, the parameters affecting the results of a study are not limited to block characteristics, such as block type, local anaesthetic volume, and concentration. Comparisons are generally made between the control and experimental groups or between more than one experimental group. Another critical factor is whether the applied regional anesthesia technique is performed before or after the surgical procedure, i.e., whether it provides pre-emptive/preventive analgesia. The common goal in pre-emptive analgesia applications such as pre-operative TAP block is to reduce the intensity and duration of postoperative pain by preventing central sensitization and reducing peripheral nociceptive input [11]. Based on the data revealing that the application of regional anesthesia to be performed early reduces the immune response to perioperative trauma, debates about whether to apply a pre- or postsurgical block are still ongoing [12, 13]. Therefore, we conducted a meta-analysis of previously published randomised controlled trials to compare the effects of pre-operative and postoperative TAP blocks in LC. Our hypothesis was that a pre-operative TAP block would reduce morphine consumption by providing pre-emptive analgesia and allowing more time for LA to diffuse in the fascial plane. Methods Eligibility criteria, literature search, and study selection This systematic review and meta-analysis followed the steps outlined by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement [14]. We followed the PRISMA extension statement for reporting systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations [15]. The Cochrane Handbook for Systematic Reviews of Intervention was chosen as the methodological guidance [16]. The protocol was registered prospectively in PROSPERO (CRD42023396880). We defined inclusion criteria using the PICOS acronym items: adult patients (≥ 18 years) who underwent LC (P) who received pre-operative or postoperative ultrasound guided TAP blocks including all approaches reported in the literature for TAP block [17] (I) compared to placebo or no intervention (C). Our primary outcome was 24-hour postoperative morphine consumption (mg). For all papers expressing the cumulative postoperative opioid dose with a drug other than morphine, we converted the amount following the equi-analgesic tables using the GlobalRPh morphine equivalent calculator, considering a 0% cross-tolerance modifier (http://www.globalrph.com/narcotic). Our pre-specified secondary outcomes were pain rest scores within 3 hours and at 12 and 24 hours expressed through the visual analogue scale (VAS) or numerical rating scale (NRS), and postoperative nausea and vomiting (PONV), defined as a self-reported outcome in the first 24 postoperative hours (O) [18]. We decided to include only RCTs (S). Regarding the TAP block timing we defined pre-operative block as a TAP block performed before the surgical incision. All blocks performed after surgical incisions were defined as postoperative blocks. We did not exclude studies based on the type of local anaesthetic and volume injected. We performed an electronic search of PubMed (via the National Library of Medicine), EMBASE, Scopus, Cochrane Central Register of Controlled Trials (CENTRAL), and Web of Science from database inception to 8 March 2023 using a predefined search strategy (Supplementary Document 1). The research strategy was decided and approved in advance by regional anesthesia experts. Language restrictions were not imposed. In this review, two reviewers (Y.E.K. and M.B.) independently identified and assessed studies to determine if they were eligible, and a third reviewer settled any disagreements that arose (B.D.). Two authors extracted data and evaluated the potential for bias separately (F.G. and A.D.C.). Data extraction and risk-of-Bias assessment Data for this systematic review were extracted using an Excel (Microsoft, Redmond, WA, USA) spreadsheet that had been specifically prepared for this purpose. Data regarding the procedure, including the year of publication, the patient’s age, the patient’s American Society of Anaesthesiologists (ASA) physical status score, the type local anaesthetic used, the injection volume, the amount of local anaesthetic used, and the TAP block technique, used was collected. Two researchers used the Risk of Bias (RoB) 2 instrument to assess the reliability of the included RCTs [16]. Randomization, allocation concealment, blinding of outcome assessment, data completeness, and selective outcome reporting were used to assign each study a risk of bias grade of either low, high, or with some concerns. The certainty and quality of the evidence for each outcome was assessed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology [19]. To check for publication bias, we generated funnel plots, and we intended to conduct additional statistical analysis of funnel plot asymmetry if more than 10 trials were evaluated for each outcome [16]. Evaluations of homogeneity, consistency, and intransitivity are given in the section on statistics that follows. Statistical analysis Data meta-analysis was conducted using the R package “netmeta” in R version 4.1 (R Foundation for Statistical Computing, Vienna, Austria). We used the χ2 test and the I2-statistic (classifying I2 values as low (25%), moderate (25–50%), or high (> 50%) to evaluate the degree of heterogeneity within the studies [19]. We used mean differences (MDs) with 95% confidence intervals (CIs) to describe the treatment’s impact on continuous variables. For binary outcomes, we report the effect as an odds ratio (OR) with 95% CI. We ranked all treatments in terms of their ability to reduce 24-hour morphine consumption, from 0 to 1, using the surface under cumulative ranking (SUCRA) curve [20]. A higher SUCRA (values closer to 1) suggests that a given treatment is more likely to be optimal for the outcome of interest. We were able to rank the treatments by comparing the SUCRA values that were calculated for each. Whenever possible, we used the Hozo method to transform the reported median and interquartile range into an estimated mean and standard deviation (SD) [21]. When different doses of local anaesthetic were used in the same study for the same block, the means and standard deviations were pooled. Cochrane’s Q test was used to assess the degree of heterogeneity within and between studies. Despite the inconsistency and heterogeneity, a random-effects model was chosen. We inspected funnel plots visually and used the Egger test (p 0.05, indicating possible publication bias) to assess publication bias (Supplementary Document 2). All statistical significance testing was 2-tailed; a p value of < 0.05 was considered statistically significant. Results The search results are presented in the PRISMA flow diagram (Fig. 1). Initial screening identified 995 studies. Of these, 82 search results were excluded during the preliminary screening because they were duplicates, and 879 were excluded because they were unrelated to the topic. The full texts were retrieved from the remaining 34 articles, and five more studies were excluded according to our inclusion and exclusion criteria. Five additional studies were identified by screening the references of the included articles. A total of 34 studies were included in the quantitative analysis [11, 22–54]. Table 1 summarises the pooled characteristics of the included studies.Fig. 1PRISMA flow diagram. The diagram illustrates the study selection process and provides reasons for excluding records during the screening. PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-AnalysesTable 1Summary of findings tableAuthor (Year)CountryAgeASALA1LA2Block TimingGA protocolPO analgesia protocolMain OutcomeRahimzadeh P (2022) [11]Iran20–60I-II20 ml of ropivacaine 0.25%20 ml of ropivacaine 0.25%Preoperative vs. PostoperativePREMEDICATION: FNT 2 μg/kg, MDZ 0.12 mg/kg INDUCTION: PRP 2 mg/ kg and cisatracurium 0.2 mg/kg MAINTENANCE: Isoflurane 1MAC (1.2%), cisatracurium 2 mg every 30 minPCA: 20 mg/ml of Acetaminophen and 0.6 mg/ml of Ketorolac with a bolus of 2 ml every 15 minPostoperative PainArik E (2020) [22]Turkey18–80I-III20 mL 0.25% bupivacaine–PreoperativePREMEDICATION: MDZ 0.03 mg/kg INDUCTION: PRP 2.5 mg/kg; FNT 1 mcg/kg; ROC 0.6 mg/kg MAINTENANCE: SEVO 1% MACPCA: tramadol (5 mg/mL) 20 mg bolus, 20 min lock-out time, and a maximum infusion rate of 200 mg in 4 h without basal infusion. Dexketoprofen 50 mg IV for rescue when NRS > 4Postoperative PainDost B (2018) [23]Turkey20–70I-IIlevobupivacaine 0.5% 15 mL+ saline 15 mL–PreoperativePREMEDICATION: MDZ 0.03 mg/kg INDUCTION: PRP 2.5 mg/kg; FNT 1 mcg/kg; ROC 0.6 mg/kg MAINTENANCE: SEVO 1% MACPCA: tramadol (5 mg/mL) 20 mg bolus, 15 min lock-out time, and a maximum infusion rate of 200 mg in 4 h with basal infusion of 5 mg/h. Meperidin 0.5 mg/kg IV for rescue when NRS > 4Postoperative PainBhatia N (2014) [24]India18–60I-IIropivacaine 0.375% 15 ml–PostoperativePREMEDICATION: alprazolam 0.25 mg + ranitidine 250 mg; INDUCTION: morphine 0.1 mg/kg PRP 2–3 mg/kg vecuronium 0.1 mg/kg; MAINTENANCE: N2O 66% +/− Isoflurane 1–2%IV paracetamol 1 g every 6 hours, VAS score greater than 4, or those requesting analgesic, were given IV tramadol 2 mg/kg; subsequent doses of tramadol, if required, were 1 mg/kgPostoperative PainOrtiz J (2012) [25]USA18–64I-IIIropivacaine 0.5% 15 mlropivacaine 0.5% 20 mlPreoperativePREMEDICATION: MDZ 1–2 mg, INDUCTION: FNT 2 mcg/kg and PRP 2.5 mg/kg, succinylcholine 1–2 mg/kg or ROC 0.6–1 mg/kg, MAINTENANCE: SEVO, additional boluses of FNT 50 mcgHydrocodone 5 mg, acetaminophen 500 mg tablets, 2 tablets for mild pain (NRS 3–5), and morphine 4 mg iv for severe pain (NRS 6–10)Postoperative PainSuseela I (2018) [26]India20–65I-IIbupivacaine 0.25% 20 mlbupivacaine 0.5% 20 mL (each port 5 mL)PostoperativePREMEDICATION: ranitidine 150 mg; metoclopramide 10 mg; MDZ 0.5 mg INDUCTION: PRP 2 mg/kg FNT 2 mcg/kg; succinylcholine 1.5 mg/kg MAINTENANCE: nitrous oxide 66%; isoflurane 0.4 to 0.8%; atracurium 0.5 mg/kgParacetamol 1 g at the beginning and 1 g/8 h (postoperative);tramadol 1 mg /kg and diclofenac 1 mg/kgPostoperative PainVrsajkov V (2018) [27]Serbia18–75I-III20 mL of 0.33% bupivacaine–PreoperativeINDUCTION: PRP (2.5 mg/kg), FNT (3 mcg/kg) and ROC (0.6–0.8 mg/kg) MAINTENANCE: SEVO.acetaminophen (1 g IV) and morphine (0.1 mg.kg − 1 s), acetaminophen (1 g/8 h IV) and dipyrone (2.5 g/12 h; tramadol (1 mg.kg − 1 /6 h) NPS ≥ 6Postoperative PainRibeiro KNSA (2019) [28]India18–55I-II40 mL of 0.35% ropivacaine–PreoperativePREMEDICATION: FNT 2 mcg/kg I.V. INDUCTION: PRP 2 mg/kg IV, 0.1 mg/kg of vecuronium I.V. MAINTENANCE: Vecuronium 0.02 mg/kg iv, air and oxygen and SEVO 1.5–2.0 dial concentration MAC of 1.paracetamol 1 g IV at extubation and 8th hourly, Tramadol 1 mg/kg was given IV whenever VAS was ≥4Postoperative PainRa YS (2010) [29]Korea20–65I-II0.25% levobupivacaine 30 mL–PreoperativePREMEDICATION: none, INDUCTION: glycopyrolate 0.2 mg and MDZ 0.05 mg/kg and introducing 2% PRP and REM 50 μg/ml, ROC 0.6 mg/kg MAINTENANCE: oxygen and nitrous oxide, PRP at 2 μg/ mlPACU: NRS > 6 ketorolac 30 mg IV, If the pain was not relieved, FNT 20 μg; in WARD: ketorolac 30 mg was injected into all the patients 3 times during postoperative 24 hours for 8 hourPostoperative PainDai LM (2022) [30]China> 18I-II20 mL 0.5% ropivacainePostoperativeINDUCTION: MDZ (0.05 mg/kg), SUF (0.03 μg/kg), ETM (0.3 mg/kg), and cisatracurium (0.15 mg/kg), MAINTENANCE: PRP (6 mg/ kg/h) and REM (0.3 μg/kg/min)100 mL of normal saline mixed with SUF (100 μg) and dezocine (20 mg); basal inf. 2 mL/h, bolus dose was 0.5 mL, and a lockout interval of 15 minMorphine ConsumptionAl-Refaey K (2016) [31]Egypt18–40I-II20 ml volume 0.25 bupivacainePreoperativeINDUCTION: PRP 1–1.5 mg/kg, FNT 1 μ/kg, and atracurium 0.5 mg/kg, MAINTENANCE: SEVO, 0.4 oxygen/air mixturemorphine (0.02 mg/kg) if VAS score ≥ 4Recruitment Rate. Adherence Rate. Adverse Events RateLee SY (2022) [32]Korea20–70I-II40 ml of 0.375% ropivacainesalinePostoperativePREMEDICATION: none, INDUCTION: lidocaine (0.5 mg/kg), PRP (2 mg/ kg), REM (0.5 mcg/kg), and ROC (0.6 mg/kg), MAINTENANCE: oxygen (fraction of inspired oxygen, 0.5), SEVO (2–3%), and REM infusion (0.1 mcg/kg/min)continuously infuse 0.2 mcg/kg of FNT every hour, and the bolus dose was 0.2 mcg/kg with a 15-min lockout timePostoperative Pulmonary Function And AnalgesiaJung J (2021) [33]Korea20–60I-III0.25% ropivacainesalinePreoperativeINDUCTION: PRP 4–6 μg/mL and REM 2–6 μg/mL, ROC 0.6–1.0 mg/kg, MAINTENANCE: PRP, REMPACU: NRS score was > 3, the nurse injected 3-mg IV oxycodone; at ward,30 mg IV ketorolac/8 h at POD0; From POD 1, per-os 50 mg tramadol was administered every 8 hoursQuality Of RecoveryBaral B (2018) [34]Nepal18–60I-II20 ml of 0.25% Bupivacaine20 ml of 0.25% BupivacainePostoperativeinduction: FNT (2 mcg/kg), PRP (2 mg/kg), and vecuronium (0.8 mg/kg), MAINTENANCE: oxygen, isoflurane, intermittent dose of vecuroniumParacetamol 1 g 6 hourly; VAS ≥4 pethidine 0.5 mg/kgPostoperative PainBasaran B (2015) [35]Turkey18–65I-IIbupivacaine 0.25% 20 ml–PreoperativePREMEDICATION: MDZ 0.03 mg/kg INDUCTION: FNT 1 μg/kg, MDZ 0.15 mg/kg, PRP 1–2 mg/kg, ROC 1 mg/kg. MAINTENANCE: SEVO, ROC infusion (0.01 mg/kg/min) and FNT (2–3 μg/kg/h).meperidine 0.5 mg/kg; paracetamol 500 mg po every 6 hours; tenoxicam 20 mg; tramadol 50 mg + 50 mg (when needed) (max dose 500 mg/24 h)Postoperative PainEl-Dawlatly AA (2009) [36]Austria22–77I-II15 mL bupivacaine–PreoperativePREMEDICATION: diazepam 10 mg po INDUCTION: PRP 1–1.5 mg/kg; FNT 2 mcg/kg; ROC 0.6 mg/kg MAINTENANCE: SEVO 1 MAC; REM 0.1 mcg/kg/minPCA: 1.5 mg bolus morphine without basic rate, 15 min locout timePostoperative Morphine ConsumptionPeterson PL (2012) [37]Denmark18–75I-III20 mL 0.5% ropivacaineisotonic saline 0,9% 20 mLPreoperativePREMEDICATION: Oral lorezepam 2 mg, INDUCTION: SUF 0.2 mcg/kg, PRP 4 mg/kg, ROC 1 mg/kg MAINTENANCE: SEVOacetaminofen 1000 mg, every 6 hours, oral ibuprofen 400 mg every 6 hours, iv morphine 5 mg request patient(0–2 hours), 2–24 hours ketobemidone oral 2.5 mg patient own decisionPostoperative PainHouben AM (2019) [38]Belgium18–75I-IIlevobupivacaine 20 mL 0.375% with epinephrine 5 mcg/mLsaline 20 mL 0.9% with epinephrine 5 mcg/mLPreoperativeINDUCTION: REM 0,4 mL/kg/h (0.6 mg/mL) PRP, MAINTENANCE: PRP, REM 0.4 mL/kg/h SUF 0.2 mcg/kgparacetamol 2 g, iv morphine 2 mg bolus,oxycodone 5 mg every 4 hours if necessaryCumulative Morphine ConsumptionLiang M (2020) [39]China18–70I-IIropivacaine 0.75% 20 mL20 mL saline 0,9%PreoperativeINDUCTION: PRP 2 mg/kg, SUF 0.1 mcg/kg, ROC 0.6 mg/kg MAINTENANCE: SEVO 1–2%parecoxib 40 mg, morphine 2.5 mg for PACU patients, tramadol 100 mg PO for those in the wardPostoperative PainShin HJ (2014) [40]USA18–65I-IIno blockropivacaine 20 mL 0.375%PreoperativeINDUCTION: PRP 1.5 mg/kg, FNT1 mcg/kg, ROC 0.6 mg/kg MAINTENANCE: SEVOketorolac 30 mg, if NRS pain score exceeded 6 add FNT 25 mcg,if 4–6, ketorolac 30 mg, on the ward nalbuphine 10 mg (if exceeded 6 or or patient requested)Postoperative PainBreazu C (2022) [41]Romania> 18I-IIbupivacaine 0.25% 20 mlno blockPreoperativeINDUCTION: PRP 2 mg/kg FNT 2mcg/kg atracurium 0.5 mg/kg or ROC 0.6 mg/kg MAINTENANCE: SEVOPostoperative PainAndic KD (2021) [42]Turkey18–75I-IIIbupivacaine 0.375% 20 mlno blockPreoperativePREMEDICATION:MDZ 0.03 mg/kg INDUCTION: FNT 2 mcg/kg PRP 1–2 mg/kg ROC 0.6 mg/kg MAINTENANCE: SEVO 1 mac REM 0.1–0.5 mcg/kg/minPCA: tramadol 500 MG basal infusion 3 mL/h bolus 3 mL lockout time 20 minPostoperative PainChen CK (2013) [43]Hong Kong21–60I-IIropivacaine 20 mL 3.75 mg/mLno blockPreoperativePREMEDICATION: oral MDZ 7,5 mg INDUCTION: FNT 2mcg/kg PRP 1–2 mg/kg Vecuronium 0.1 mg/kg MAINTENANCE: SEVO; vecuronium 0.05 mg/kgif VAS score more than 4, morphine 0.05 mg/kgMorphine ConsumptionTolchard S (2014) [44]England> 16I-IIbupivacaine 1 mg/kgbupivacaine 1 mg/ kg port sitePostoperativeINDUCTION: PRP 2.5 mg/kg FNT 3 mcg/kg atracurium 0.6 mg/kgintraoperative: paracetamol 15–20 mg/kg diclofenac 0.5 mg/kg, postoperative: FNT 20 mcg bolusesPostoperative PainBreazu CM (2016) [45]Romania> 18I-IIsaline 20 mLbupivacaine 0.25% 20 mLPreoperativePREMEDICATION: MDZ 7.5 mg po INDUCTION: PRP 2 mg/kg FNT 2 mcg/kg; ROC 0.6 mg/kg or atracurium 0.5 mg/kg MAINTENANCE: SEVO 1–2 MAC FNT 100 mcg when neededAcetaminofen 15–20 mg/kg and 1 g iv at 8 h, pethidine 20–40 mg boluses and 20–40 mg iv every 3 hoursPostoperative PainHuang SH (2016) [46]ChinaI-IIropivacaine 15 mL 0.375%no blockPreoperativeINDUCTION: midozolam 0.05 mg/kg PRP 2% REM ROC 0.6 mg/kg MAINTENANCE: PRP 2 mcg/mL REM 2–4 ng/mL ROC if needed40 mg iv parecoxib, iv sulfentanil 5–10 mcgPostoperative PainSaliminia A (2015) [47]Iranbupivacaine 0.5% 30 mL + 2 mL saline32 mL saline 0.9%PostoperativeINDUCTION: PRP 2 mg/kg, FNT 3 mcg/kg, atracurium 0.6 mg/kg MAINTENANCE: PRP 80–100 mcg/kg/min, FNT 1 mcg/kg/ 30 min, atracurium 0.3 mg/kg/30 minPCA: FNT 50 mcg bolus; lock out time 8 minPostoperative Opioid ConsumptionAli L (2018) [48]Pakistan20–60I-II0.5% bupivacaine (1 mg/kg),0.5% bupivacaine (1 mg/kg),PostoperativeINDUCTION:iv Nalbuphine 0.1 mg/kg, PRP 2–2.5 mg/kg iv MAINTENANCE isoflurane in 50% oxygen with airNalbuphine 2 mg ivPostoperative PainBava P (2016) [49]India18–65I-II0.375% ropivacaine0.25% bupivacainePreoperativeINDUCTION:PRP 2 mg/kg + FNT 2 μg/kg + atracurium 0.5 mg/kg MAINTENANCE: isofluraneMorphine 0.05 mg/kg boluses given until the VAS score < 4 + PCA (1 mg bolus) + as rescue analgesia if VAS > 3 0.1 mg/kg of morphine IPostoperative PainPaudal B (2022) [50]Nepal18–60I-IIbupivacaine 20 mL 0.25%bupivacaine 20 mL 0.25%PostoperativePREMEDICATION: ranitidine 150 mg po INDUCTION: MDZ 0,02 mg/kg FNT 2 mcg/kg PRP 2.5 mg/kg vecuronium 0.1 mg/kg MAINTENANCE: isoflurane 1–1.5% intermittent doses of ROCPostoperative PainEmile SH (2022) [51]EgyptN/AI-II10 ml bupivacaine (0.25%) + lidocaine (%2) + 10 ml salineno blockPostoperativeINDUCTION: PRP 2 mg/kg, atracorium 1 mg/kg, FNT 1 μg/kgIV 1000 mg Paracetamol, if VAS > 4 iv diclofenac for rescue analgesicpostoperative painChoi Y (2017) [52]Korea19–70I-II20 mL of ropivacaine 0.2%no blockPreoperativePREMEDICATION: glycopyrrolate(0.003 mg/kg) and MDZ (0.05 mg/kg) INDUCTION: thiopental sodium (5 mg/kg) and REM (1 μg/kg/min) ROC (0.8 mg/kg) MAINTENANCE: Desflurane (6 vol%) REM 0.5–1 μg/kg/minIV-PCA: 100 mL of normal saline mixed with oxycodone (40 mg) and ketorolac (180 mg). The basal infusion rate was set to 1 mL/h, the bolus dose was 1 mL, and the lockout time was 15 minpostoperative painPrajapati K (2022) [53]IndiaN/AI-II20 mL of 0.375% ropivacaineno blockPostoperativeINDUCTION: FNT 2 mcg/kg, PRP 1.5–2.5 mg/kg and atracurium 0.5 mg/kg. MAINTENANCE: nitrous oxide (60%) and isoflurane (MAC: 0.8–1.2) in oxygen.Paracetamol 1 g iv six hourly and inj. Diclofenac (75 mg/mL) 1 mL diluted in 100 mL normal saline iv 12 hourly. VAS ≥ 4 IV tramadol at an incremental dose of 2 mg/kg as rescue analgesiapostoperative painErgin A (2021) [54]Turkey18–74I-III40 ml of bupivacaine 0.25%no blockPreoperativeINDUCTION: 2–3 mg/kg PRP, 2 μg/kgFNT, and 0.6 mg/kg ROCMAINTENANCE:1.5–2% SEVOVAS score of > 4 50 mg tramadol IV, and those with ongoing high pain after 30 min 100 mg tramadol, tenoxicam 20 mg IV postop 8 h, and 25 mg of meperidine IV as salvage analgesicpostoperative painAbbreviations: MDZ midazolam, SUF sufentanil, REM remifentanil, ETM etomidate, ROC rocuronium, PRP propofol, PCA patient-controlled analgesia, FNT fentanil, SEVO sevoflurane, VAS visual analog scale, NRS numerical rating scale PRISMA flow diagram. The diagram illustrates the study selection process and provides reasons for excluding records during the screening. PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses Table 1Summary of findings tableAuthor (Year)CountryAgeASALA1LA2Block TimingGA protocolPO analgesia protocolMain OutcomeRahimzadeh P (2022) [11]Iran20–60I-II20 ml of ropivacaine 0.25%20 ml of ropivacaine 0.25%Preoperative vs. PostoperativePREMEDICATION: FNT 2 μg/kg, MDZ 0.12 mg/kg INDUCTION: PRP 2 mg/ kg and cisatracurium 0.2 mg/kg MAINTENANCE: Isoflurane 1MAC (1.2%), cisatracurium 2 mg every 30 minPCA: 20 mg/ml of Acetaminophen and 0.6 mg/ml of Ketorolac with a bolus of 2 ml every 15 minPostoperative PainArik E (2020) [22]Turkey18–80I-III20 mL 0.25% bupivacaine–PreoperativePREMEDICATION: MDZ 0.03 mg/kg INDUCTION: PRP 2.5 mg/kg; FNT 1 mcg/kg; ROC 0.6 mg/kg MAINTENANCE: SEVO 1% MACPCA: tramadol (5 mg/mL) 20 mg bolus, 20 min lock-out time, and a maximum infusion rate of 200 mg in 4 h without basal infusion. Dexketoprofen 50 mg IV for rescue when NRS > 4Postoperative PainDost B (2018) [23]Turkey20–70I-IIlevobupivacaine 0.5% 15 mL+ saline 15 mL–PreoperativePREMEDICATION: MDZ 0.03 mg/kg INDUCTION: PRP 2.5 mg/kg; FNT 1 mcg/kg; ROC 0.6 mg/kg MAINTENANCE: SEVO 1% MACPCA: tramadol (5 mg/mL) 20 mg bolus, 15 min lock-out time, and a maximum infusion rate of 200 mg in 4 h with basal infusion of 5 mg/h. Meperidin 0.5 mg/kg IV for rescue when NRS > 4Postoperative PainBhatia N (2014) [24]India18–60I-IIropivacaine 0.375% 15 ml–PostoperativePREMEDICATION: alprazolam 0.25 mg + ranitidine 250 mg; INDUCTION: morphine 0.1 mg/kg PRP 2–3 mg/kg vecuronium 0.1 mg/kg; MAINTENANCE: N2O 66% +/− Isoflurane 1–2%IV paracetamol 1 g every 6 hours, VAS score greater than 4, or those requesting analgesic, were given IV tramadol 2 mg/kg; subsequent doses of tramadol, if required, were 1 mg/kgPostoperative PainOrtiz J (2012) [25]USA18–64I-IIIropivacaine 0.5% 15 mlropivacaine 0.5% 20 mlPreoperativePREMEDICATION: MDZ 1–2 mg, INDUCTION: FNT 2 mcg/kg and PRP 2.5 mg/kg, succinylcholine 1–2 mg/kg or ROC 0.6–1 mg/kg, MAINTENANCE: SEVO, additional boluses of FNT 50 mcgHydrocodone 5 mg, acetaminophen 500 mg tablets, 2 tablets for mild pain (NRS 3–5), and morphine 4 mg iv for severe pain (NRS 6–10)Postoperative PainSuseela I (2018) [26]India20–65I-IIbupivacaine 0.25% 20 mlbupivacaine 0.5% 20 mL (each port 5 mL)PostoperativePREMEDICATION: ranitidine 150 mg; metoclopramide 10 mg; MDZ 0.5 mg INDUCTION: PRP 2 mg/kg FNT 2 mcg/kg; succinylcholine 1.5 mg/kg MAINTENANCE: nitrous oxide 66%; isoflurane 0.4 to 0.8%; atracurium 0.5 mg/kgParacetamol 1 g at the beginning and 1 g/8 h (postoperative);tramadol 1 mg /kg and diclofenac 1 mg/kgPostoperative PainVrsajkov V (2018) [27]Serbia18–75I-III20 mL of 0.33% bupivacaine–PreoperativeINDUCTION: PRP (2.5 mg/kg), FNT (3 mcg/kg) and ROC (0.6–0.8 mg/kg) MAINTENANCE: SEVO.acetaminophen (1 g IV) and morphine (0.1 mg.kg − 1 s), acetaminophen (1 g/8 h IV) and dipyrone (2.5 g/12 h; tramadol (1 mg.kg − 1 /6 h) NPS ≥ 6Postoperative PainRibeiro KNSA (2019) [28]India18–55I-II40 mL of 0.35% ropivacaine–PreoperativePREMEDICATION: FNT 2 mcg/kg I.V. INDUCTION: PRP 2 mg/kg IV, 0.1 mg/kg of vecuronium I.V. MAINTENANCE: Vecuronium 0.02 mg/kg iv, air and oxygen and SEVO 1.5–2.0 dial concentration MAC of 1.paracetamol 1 g IV at extubation and 8th hourly, Tramadol 1 mg/kg was given IV whenever VAS was ≥4Postoperative PainRa YS (2010) [29]Korea20–65I-II0.25% levobupivacaine 30 mL–PreoperativePREMEDICATION: none, INDUCTION: glycopyrolate 0.2 mg and MDZ 0.05 mg/kg and introducing 2% PRP and REM 50 μg/ml, ROC 0.6 mg/kg MAINTENANCE: oxygen and nitrous oxide, PRP at 2 μg/ mlPACU: NRS > 6 ketorolac 30 mg IV, If the pain was not relieved, FNT 20 μg; in WARD: ketorolac 30 mg was injected into all the patients 3 times during postoperative 24 hours for 8 hourPostoperative PainDai LM (2022) [30]China> 18I-II20 mL 0.5% ropivacainePostoperativeINDUCTION: MDZ (0.05 mg/kg), SUF (0.03 μg/kg), ETM (0.3 mg/kg), and cisatracurium (0.15 mg/kg), MAINTENANCE: PRP (6 mg/ kg/h) and REM (0.3 μg/kg/min)100 mL of normal saline mixed with SUF (100 μg) and dezocine (20 mg); basal inf. 2 mL/h, bolus dose was 0.5 mL, and a lockout interval of 15 minMorphine ConsumptionAl-Refaey K (2016) [31]Egypt18–40I-II20 ml volume 0.25 bupivacainePreoperativeINDUCTION: PRP 1–1.5 mg/kg, FNT 1 μ/kg, and atracurium 0.5 mg/kg, MAINTENANCE: SEVO, 0.4 oxygen/air mixturemorphine (0.02 mg/kg) if VAS score ≥ 4Recruitment Rate. Adherence Rate. Adverse Events RateLee SY (2022) [32]Korea20–70I-II40 ml of 0.375% ropivacainesalinePostoperativePREMEDICATION: none, INDUCTION: lidocaine (0.5 mg/kg), PRP (2 mg/ kg), REM (0.5 mcg/kg), and ROC (0.6 mg/kg), MAINTENANCE: oxygen (fraction of inspired oxygen, 0.5), SEVO (2–3%), and REM infusion (0.1 mcg/kg/min)continuously infuse 0.2 mcg/kg of FNT every hour, and the bolus dose was 0.2 mcg/kg with a 15-min lockout timePostoperative Pulmonary Function And AnalgesiaJung J (2021) [33]Korea20–60I-III0.25% ropivacainesalinePreoperativeINDUCTION: PRP 4–6 μg/mL and REM 2–6 μg/mL, ROC 0.6–1.0 mg/kg, MAINTENANCE: PRP, REMPACU: NRS score was > 3, the nurse injected 3-mg IV oxycodone; at ward,30 mg IV ketorolac/8 h at POD0; From POD 1, per-os 50 mg tramadol was administered every 8 hoursQuality Of RecoveryBaral B (2018) [34]Nepal18–60I-II20 ml of 0.25% Bupivacaine20 ml of 0.25% BupivacainePostoperativeinduction: FNT (2 mcg/kg), PRP (2 mg/kg), and vecuronium (0.8 mg/kg), MAINTENANCE: oxygen, isoflurane, intermittent dose of vecuroniumParacetamol 1 g 6 hourly; VAS ≥4 pethidine 0.5 mg/kgPostoperative PainBasaran B (2015) [35]Turkey18–65I-IIbupivacaine 0.25% 20 ml–PreoperativePREMEDICATION: MDZ 0.03 mg/kg INDUCTION: FNT 1 μg/kg, MDZ 0.15 mg/kg, PRP 1–2 mg/kg, ROC 1 mg/kg. MAINTENANCE: SEVO, ROC infusion (0.01 mg/kg/min) and FNT (2–3 μg/kg/h).meperidine 0.5 mg/kg; paracetamol 500 mg po every 6 hours; tenoxicam 20 mg; tramadol 50 mg + 50 mg (when needed) (max dose 500 mg/24 h)Postoperative PainEl-Dawlatly AA (2009) [36]Austria22–77I-II15 mL bupivacaine–PreoperativePREMEDICATION: diazepam 10 mg po INDUCTION: PRP 1–1.5 mg/kg; FNT 2 mcg/kg; ROC 0.6 mg/kg MAINTENANCE: SEVO 1 MAC; REM 0.1 mcg/kg/minPCA: 1.5 mg bolus morphine without basic rate, 15 min locout timePostoperative Morphine ConsumptionPeterson PL (2012) [37]Denmark18–75I-III20 mL 0.5% ropivacaineisotonic saline 0,9% 20 mLPreoperativePREMEDICATION: Oral lorezepam 2 mg, INDUCTION: SUF 0.2 mcg/kg, PRP 4 mg/kg, ROC 1 mg/kg MAINTENANCE: SEVOacetaminofen 1000 mg, every 6 hours, oral ibuprofen 400 mg every 6 hours, iv morphine 5 mg request patient(0–2 hours), 2–24 hours ketobemidone oral 2.5 mg patient own decisionPostoperative PainHouben AM (2019) [38]Belgium18–75I-IIlevobupivacaine 20 mL 0.375% with epinephrine 5 mcg/mLsaline 20 mL 0.9% with epinephrine 5 mcg/mLPreoperativeINDUCTION: REM 0,4 mL/kg/h (0.6 mg/mL) PRP, MAINTENANCE: PRP, REM 0.4 mL/kg/h SUF 0.2 mcg/kgparacetamol 2 g, iv morphine 2 mg bolus,oxycodone 5 mg every 4 hours if necessaryCumulative Morphine ConsumptionLiang M (2020) [39]China18–70I-IIropivacaine 0.75% 20 mL20 mL saline 0,9%PreoperativeINDUCTION: PRP 2 mg/kg, SUF 0.1 mcg/kg, ROC 0.6 mg/kg MAINTENANCE: SEVO 1–2%parecoxib 40 mg, morphine 2.5 mg for PACU patients, tramadol 100 mg PO for those in the wardPostoperative PainShin HJ (2014) [40]USA18–65I-IIno blockropivacaine 20 mL 0.375%PreoperativeINDUCTION: PRP 1.5 mg/kg, FNT1 mcg/kg, ROC 0.6 mg/kg MAINTENANCE: SEVOketorolac 30 mg, if NRS pain score exceeded 6 add FNT 25 mcg,if 4–6, ketorolac 30 mg, on the ward nalbuphine 10 mg (if exceeded 6 or or patient requested)Postoperative PainBreazu C (2022) [41]Romania> 18I-IIbupivacaine 0.25% 20 mlno blockPreoperativeINDUCTION: PRP 2 mg/kg FNT 2mcg/kg atracurium 0.5 mg/kg or ROC 0.6 mg/kg MAINTENANCE: SEVOPostoperative PainAndic KD (2021) [42]Turkey18–75I-IIIbupivacaine 0.375% 20 mlno blockPreoperativePREMEDICATION:MDZ 0.03 mg/kg INDUCTION: FNT 2 mcg/kg PRP 1–2 mg/kg ROC 0.6 mg/kg MAINTENANCE: SEVO 1 mac REM 0.1–0.5 mcg/kg/minPCA: tramadol 500 MG basal infusion 3 mL/h bolus 3 mL lockout time 20 minPostoperative PainChen CK (2013) [43]Hong Kong21–60I-IIropivacaine 20 mL 3.75 mg/mLno blockPreoperativePREMEDICATION: oral MDZ 7,5 mg INDUCTION: FNT 2mcg/kg PRP 1–2 mg/kg Vecuronium 0.1 mg/kg MAINTENANCE: SEVO; vecuronium 0.05 mg/kgif VAS score more than 4, morphine 0.05 mg/kgMorphine ConsumptionTolchard S (2014) [44]England> 16I-IIbupivacaine 1 mg/kgbupivacaine 1 mg/ kg port sitePostoperativeINDUCTION: PRP 2.5 mg/kg FNT 3 mcg/kg atracurium 0.6 mg/kgintraoperative: paracetamol 15–20 mg/kg diclofenac 0.5 mg/kg, postoperative: FNT 20 mcg bolusesPostoperative PainBreazu CM (2016) [45]Romania> 18I-IIsaline 20 mLbupivacaine 0.25% 20 mLPreoperativePREMEDICATION: MDZ 7.5 mg po INDUCTION: PRP 2 mg/kg FNT 2 mcg/kg; ROC 0.6 mg/kg or atracurium 0.5 mg/kg MAINTENANCE: SEVO 1–2 MAC FNT 100 mcg when neededAcetaminofen 15–20 mg/kg and 1 g iv at 8 h, pethidine 20–40 mg boluses and 20–40 mg iv every 3 hoursPostoperative PainHuang SH (2016) [46]ChinaI-IIropivacaine 15 mL 0.375%no blockPreoperativeINDUCTION: midozolam 0.05 mg/kg PRP 2% REM ROC 0.6 mg/kg MAINTENANCE: PRP 2 mcg/mL REM 2–4 ng/mL ROC if needed40 mg iv parecoxib, iv sulfentanil 5–10 mcgPostoperative PainSaliminia A (2015) [47]Iranbupivacaine 0.5% 30 mL + 2 mL saline32 mL saline 0.9%PostoperativeINDUCTION: PRP 2 mg/kg, FNT 3 mcg/kg, atracurium 0.6 mg/kg MAINTENANCE: PRP 80–100 mcg/kg/min, FNT 1 mcg/kg/ 30 min, atracurium 0.3 mg/kg/30 minPCA: FNT 50 mcg bolus; lock out time 8 minPostoperative Opioid ConsumptionAli L (2018) [48]Pakistan20–60I-II0.5% bupivacaine (1 mg/kg),0.5% bupivacaine (1 mg/kg),PostoperativeINDUCTION:iv Nalbuphine 0.1 mg/kg, PRP 2–2.5 mg/kg iv MAINTENANCE isoflurane in 50% oxygen with airNalbuphine 2 mg ivPostoperative PainBava P (2016) [49]India18–65I-II0.375% ropivacaine0.25% bupivacainePreoperativeINDUCTION:PRP 2 mg/kg + FNT 2 μg/kg + atracurium 0.5 mg/kg MAINTENANCE: isofluraneMorphine 0.05 mg/kg boluses given until the VAS score < 4 + PCA (1 mg bolus) + as rescue analgesia if VAS > 3 0.1 mg/kg of morphine IPostoperative PainPaudal B (2022) [50]Nepal18–60I-IIbupivacaine 20 mL 0.25%bupivacaine 20 mL 0.25%PostoperativePREMEDICATION: ranitidine 150 mg po INDUCTION: MDZ 0,02 mg/kg FNT 2 mcg/kg PRP 2.5 mg/kg vecuronium 0.1 mg/kg MAINTENANCE: isoflurane 1–1.5% intermittent doses of ROCPostoperative PainEmile SH (2022) [51]EgyptN/AI-II10 ml bupivacaine (0.25%) + lidocaine (%2) + 10 ml salineno blockPostoperativeINDUCTION: PRP 2 mg/kg, atracorium 1 mg/kg, FNT 1 μg/kgIV 1000 mg Paracetamol, if VAS > 4 iv diclofenac for rescue analgesicpostoperative painChoi Y (2017) [52]Korea19–70I-II20 mL of ropivacaine 0.2%no blockPreoperativePREMEDICATION: glycopyrrolate(0.003 mg/kg) and MDZ (0.05 mg/kg) INDUCTION: thiopental sodium (5 mg/kg) and REM (1 μg/kg/min) ROC (0.8 mg/kg) MAINTENANCE: Desflurane (6 vol%) REM 0.5–1 μg/kg/minIV-PCA: 100 mL of normal saline mixed with oxycodone (40 mg) and ketorolac (180 mg). The basal infusion rate was set to 1 mL/h, the bolus dose was 1 mL, and the lockout time was 15 minpostoperative painPrajapati K (2022) [53]IndiaN/AI-II20 mL of 0.375% ropivacaineno blockPostoperativeINDUCTION: FNT 2 mcg/kg, PRP 1.5–2.5 mg/kg and atracurium 0.5 mg/kg. MAINTENANCE: nitrous oxide (60%) and isoflurane (MAC: 0.8–1.2) in oxygen.Paracetamol 1 g iv six hourly and inj. Diclofenac (75 mg/mL) 1 mL diluted in 100 mL normal saline iv 12 hourly. VAS ≥ 4 IV tramadol at an incremental dose of 2 mg/kg as rescue analgesiapostoperative painErgin A (2021) [54]Turkey18–74I-III40 ml of bupivacaine 0.25%no blockPreoperativeINDUCTION: 2–3 mg/kg PRP, 2 μg/kgFNT, and 0.6 mg/kg ROCMAINTENANCE:1.5–2% SEVOVAS score of > 4 50 mg tramadol IV, and those with ongoing high pain after 30 min 100 mg tramadol, tenoxicam 20 mg IV postop 8 h, and 25 mg of meperidine IV as salvage analgesicpostoperative painAbbreviations: MDZ midazolam, SUF sufentanil, REM remifentanil, ETM etomidate, ROC rocuronium, PRP propofol, PCA patient-controlled analgesia, FNT fentanil, SEVO sevoflurane, VAS visual analog scale, NRS numerical rating scale Summary of findings table PREMEDICATION: glycopyrrolate (0.003 mg/kg) and MDZ (0.05 mg/kg) INDUCTION: thiopental sodium (5 mg/kg) and REM (1 μg/kg/min) ROC (0.8 mg/kg) MAINTENANCE: Desflurane (6 vol%) REM 0.5–1 μg/kg/min INDUCTION: 2–3 mg/kg PRP, 2 μg/kg FNT, and 0.6 mg/kg ROC MAINTENANCE:1.5–2% SEVO Abbreviations: MDZ midazolam, SUF sufentanil, REM remifentanil, ETM etomidate, ROC rocuronium, PRP propofol, PCA patient-controlled analgesia, FNT fentanil, SEVO sevoflurane, VAS visual analog scale, NRS numerical rating scale In total, 22 of the included studies compared pre-operative TAP block with a control [22, 23, 25, 27–29, 31, 33, 35–43, 45, 46, 49, 52, 54], 11 evaluated the effect of postoperative TAP block compared with a control block [24, 26, 30, 32, 34, 44, 47, 48, 50, 51, 53], and only one directly compared pre-operative TAP block with postoperative TAP block [11]. A total of 2317 patients were enrolled in the included trials: 456 patients were randomised to the postoperative TAP block group, 773 to the pre-operative TAP block group, and the remaining to the control group. According to the risk of bias assessment, eight studies had a low risk of bias and three had a high risk. The 23 studies raised some concerns (Fig. 2). The criteria we used to assign the risk of bias judgments can be found in Supplementary Document 3.Fig. 2Bias assessment. An overview of the ROB2 (Risk of Bias 2) assessment is presented in this figure Bias assessment. An overview of the ROB2 (Risk of Bias 2) assessment is presented in this figure Outcomes Most evidence arises from indirect comparisons, given that only one trial directly compared pre-operative and postoperative TAP blocks. While the cumulative effects of direct and indirect evidence are shown in the following section, the contribution of direct evidence for each comparison is shown in in Supplementary Document 4. Publication Bias There was evidence of publication bias only for PONV outcomes (Egger’s test, p = 0.015). All funnel plots are shown in Supplementary Document 2. Main outcome: postoperative opioid consumption at 24 hours Postoperative opioid consumption was evaluated in 25 studies. A graphical representation of the network is shown in Fig. 3. Both postoperative and pre-operative TAP blocks resulted in a better reduction in opioid consumption at 24 h than the control (Table 2). However, the postoperative TAP block was superior to the pre-operative TAP block (MD 2.02, 95% CI 0.87. to 3.18, I2 98.6%, p < 0.001) (Table 2). Using the GRADE assessment, we rated the quality of evidence as low, given both the high statistical heterogeneity and the major contribution of indirect evidence to the results.Fig. 3Network plot for intravenous morphine equivalents (mg) in the first 24 h. Each technique is represented at each corner of the polygon. The widths of the lines connecting interventions are proportionate to the number of trials assessing the comparisonsTable 2Postoperative vs. preoperative comparisonkMD (95% CI)p-valueI2Tau2MME 24 h25Preoperative2.02 (0.87;3.18)< 0.00198.6%1.124Control3.86 (2.90;44,82)< 0.001Pain (0–3)28Preoperative0.17 (−0.49;0.83)0.62197.8%0.661Control1.70 (1.13;2.27)< 0.001Pain 12 h21Preoperative0.30 (−0.44; 1.03)0.42993.6%0.697Control1.43 (0.81;2.05)< 0.001Pain 24 h26Preoperative0.36 (−0.14;0.87)0.15796.3%0.356Control1.06 (0.62;1.50)< 0.001kOR (95% CI)p-valueI2Tau2PONV21Preoperative2.21 (1.20;4.08)0.01137.8%0.197Control2.26 (1.36;3.76)0.002Postoperative TAP block is the reference group. “k” refers to the number of studies included in the analysis Network plot for intravenous morphine equivalents (mg) in the first 24 h. Each technique is represented at each corner of the polygon. The widths of the lines connecting interventions are proportionate to the number of trials assessing the comparisons Table 2Postoperative vs. preoperative comparisonkMD (95% CI)p-valueI2Tau2MME 24 h25Preoperative2.02 (0.87;3.18)< 0.00198.6%1.124Control3.86 (2.90;44,82)< 0.001Pain (0–3)28Preoperative0.17 (−0.49;0.83)0.62197.8%0.661Control1.70 (1.13;2.27)< 0.001Pain 12 h21Preoperative0.30 (−0.44; 1.03)0.42993.6%0.697Control1.43 (0.81;2.05)< 0.001Pain 24 h26Preoperative0.36 (−0.14;0.87)0.15796.3%0.356Control1.06 (0.62;1.50)< 0.001kOR (95% CI)p-valueI2Tau2PONV21Preoperative2.21 (1.20;4.08)0.01137.8%0.197Control2.26 (1.36;3.76)0.002Postoperative TAP block is the reference group. “k” refers to the number of studies included in the analysis Postoperative vs. preoperative comparison Postoperative TAP block is the reference group. “k” refers to the number of studies included in the analysis Postoperative pain Pain in the first 3 hours was evaluated in 28 studies. Meanwhile, it was reported in 21 and 26 studies at 12 and 24 postoperative hours, respectively. Both techniques were superior to the control in providing better pain control at all times (Table 2). However, neither pre-operative nor postoperative TAP blocks were superior to each other at any of the considered time points (Table 2). A comprehensive summary of the results for this outcome are depicted in Fig.4. The postoperative TAP block was always ranked as the best intervention using SUCRA (Table 3). Using the GRADE assessment, we rated the quality of evidence as low, given both the high statistical heterogeneity and the major contribution of indirect evidence to the results.Fig. 4Forest plots for the pain scores. This figure displays the forest plots for the pain scores, providing a graphical representation of the results from individual studiesTable 3SUCRAMMEPain (0–3)Pain 12Pain 24PONVPreoperative2 (0.500)2 (0.655)2 (0.607)2 (0.539)2 (0.275)Postoperative1 (0.999)1 (0.845)1 (0.892)1 (0.960)1 (0.996)Control3 (0.000)3 (0.000)3 (0.000)3 (0.000)3 (0.228)PONV Postoperative nausea and vomiting Forest plots for the pain scores. This figure displays the forest plots for the pain scores, providing a graphical representation of the results from individual studies Table 3SUCRAMMEPain (0–3)Pain 12Pain 24PONVPreoperative2 (0.500)2 (0.655)2 (0.607)2 (0.539)2 (0.275)Postoperative1 (0.999)1 (0.845)1 (0.892)1 (0.960)1 (0.996)Control3 (0.000)3 (0.000)3 (0.000)3 (0.000)3 (0.228)PONV Postoperative nausea and vomiting SUCRA PONV Postoperative nausea and vomiting PONV PONV was evaluated in 21 studies. The highest reduction in PONV was obtained with the postoperative TAP block (Table 2). Using the GRADE assessment, we rated the quality of evidence as low, given the major contribution of indirect evidence to the results, moderate statistical heterogeneity (I2 = 37.8%), and possible publication bias. Discussion This systematic review and meta-analysis evaluated the analgesic effects of pre-operative and postoperative TAP blocks in patients undergoing LC. Based on 34 randomised controlled trials, we found that postoperative TAP block reduced postoperative 24-hour opioid consumption and PONV compared to pre-operative TAP block. The VAS scores were similar in the two groups. Pain following laparoscopy has somatic, visceral, and referral components. Somatic pain arises from skin incisions during surgical port insertion, stretching of the abdominal wall due to CO2 insufflation, and surgical stimulation of the parietal peritoneum. It travels across the thoracolumbar spinal nerves (T6-L1), leading to sharp and well-localised pain rather than dull pain. In contrast, tissue traction, compression, or surgical dissection of the abdominal organs causes diffuse and dull visceral pain [1, 55]. This latter noxious impulse is transmitted by autonomic nerves (T5–9, greater splanchnic nerve, celiac ganglion, and vagus) [56, 57]. Furthermore, pneumoperitoneum and gallbladder stimulation may cause diaphragm inflammation, activating the phrenic nerve (C3–5) and causing referred shoulder pain [55]. The most significant component, in this case, is somatic pain [1]. As a component of multimodal therapy, TAP block guarantees somatic analgesia in the anterolateral abdominal wall by blocking the anterior branches of the thoracolumbar spinal nerves at different levels (T6-L1) [17]. Two meta-analyses compared TAP block to local anaesthetic wound infiltration or the control group, proving superior 24-hour postoperative analgesia [6, 58]. Pre-emptive analgesia blocks the noxious stimuli before they arise. Therefore, it is thought to be more effective than postoperative analgesia in preventing central sensitisation and incisional and inflammatory damage [59]. Therefore, we hypothesised that a pre-operative TAP block would reduce morphine consumption by providing pre-emptive analgesia and allowing more time for LA to diffuse in the fascial plane. Our results contradict these findings. A possible explanation for this discrepancy in the results could be that we included four approaches of TAP blocks, leading to different dermatomal coverages (subcostal, T6–9; lateral, T10–12; posterior, T9–12; and oblique-subcostal approach, T6-L1) [17]. Different dermatomal distributions ‘according to different approach of TAP block such as subcostal, lateral, and posterior’ among the studies may have inadvertently introduced variability in the degree of analgesia provided to the included study participants. This variability in dermatomal coverage could have directly influenced post-operative pain perception and, consequently, morphine consumption. The optimum timing for performing a TAP block is still debated in the literature. A previous meta-analysis compared the analgesic effects of pre-operative and postoperative TAP blocks on postoperative pain in patients undergoing laparoscopic surgery [60]. The analysis found that pre-operative blocks reduced postoperative pain scores. In contrast, a retrospective study showed that 20 mL of 0.25% plain bupivacaine used for postoperative and pre-operative TAP block had a slightly similar effectiveness in reducing intravenous opioid consumption in the postoperative period. In patients that underwent postoperative TAP block, there was a decreased use of patient controlled analgesia (PCA) but a higher amount of morphine consumption. There was no difference between the groups regarding the duration of PCA or intravenous and oral opioid use [61]. In the same study, Kalu et al. proved better long-term outcomes (opioid prescribed at the discharge and amount of opioid) in the postoperative TAP group. This network meta-analysis suggests that performing the block in the postoperative period may reduce 24-hour postoperative opioid consumption and PONV and may be slightly superior in terms of postoperative pain scores. Most of the evidence collected in this meta-analysis was indirect. However, a randomised controlled study comparing the timing of the block on postoperative outcomes found that performing a TAP block in the postoperative period significantly decreased postoperative opioid consumption, PONV, and pain scores at rest and during coughing [11]. Multimodal analgesia often relies heavily on opioids, which carry the risk of adverse effects, including nausea, constipation, respiratory depression, and the potential for addiction. In contrast, opioid-sparing analgesia techniques, such as the utilization of TAP blocks, aim to minimize opioid consumption while effectively controlling pain, reducing opioid-related side effects, and expediting postoperative recovery. By reducing opioid usage, patients experience improved pain control, faster return of bowel function, decreased length of hospital stay, and a quicker return to their normal daily activities [8]. Although there is still no agreement to define a clinically significant power of intervention [62], the overall reduction in opioid consumption found in this network meta-analysis was modest (− 2.23 mg), suggesting a small effect. However, considering the concomitant reduction in opioid-related PONV and postoperative pain scores, performing postoperative TAP block may be beneficial. Further studies are needed to confirm our findings, given the relatively low quality of evidence. In addition, a TAP block requires a high-volume injection in a relatively highly vascularised area. After administration, peak plasma concentrations of ropivacaine and lidocaine were reached at the 30th and 15th minutes, respectively [63, 64]. Considering that the most intense pain occurs in the early postoperative hours, it may be more reasonable to perform a TAP block postoperatively. Recent clinical findings suggest that the duration of a single shot TAP block can exceed 12 hours, with benefits reported up to 24–48 hours postoperatively for the posterior approach [65]. However, Støving et al. [66] reported in healthy volunteers a high variability effect of the block in terms of cutaneous sensory block area and block duration, which did not exceed 10 hours. In a pharmacokinetic study conducted by Trabelsi et al. [67] the mean elimination half-life of bupivacaine was 8.75 hours after the block. This result suggests a potentially decremental effect over 24 hours related to the metabolism and clearance of the local anaesthetic. The fact that the postoperative TAP block was closer to the assessment of outcomes and the peak of postoperative pain may partially explain its greater effectiveness. Our meta-analysis is subject to several limitations; thus, caution should be exercised when interpreting our results. Firstly, there was considerable variation in the concentration, dose, and type of local anaesthetic used across the different TAP blocks included in the studies. Secondly, we encompassed all types of TAP blocks, which could introduce heterogeneity and impact the overall findings. Thirdly, the majority of the reported evidence is based on indirect comparisons, as only one study provided a direct comparison. Fourthly, it is important to acknowledge that data pertaining to block performance time and block dermatomal assessment were not available in the included studies. The absence of perioperative data in many of the studies may have influenced the quality of our analysis [68, 69]. Lastly, we observed significant heterogeneity in our analysis, which may affect the reliability and generalizability of the results. Conclusions This systematic review and meta-analysis demonstrates that both pre-operative and postoperative TAP blocks are effective in reducing postoperative opioid consumption and pain scores. The postoperative TAP block appears to have a slight superiority and effectiveness in reducing 24-hour postoperative opioid consumption and PONV. However, it is essential to note that a high level of heterogeneity in the results may limit the robustness of our findings. Therefore, future studies on this topic will be of paramount importance to further validate and strengthen these results. Supplementary Information Additional file 1: Supplementary material 1. Search Strategy.Additional file 2: Supplementary material 2. Funnel Plots.Additional file 3: Supplementary Document 3. Risk of bias assessment.Additional file 4: Supp. 4. Proportion of direct evidence for each comparison. Additional file 1: Supplementary material 1. Search Strategy. Additional file 2: Supplementary material 2. Funnel Plots. Additional file 3: Supplementary Document 3. Risk of bias assessment. Additional file 4: Supp. 4. Proportion of direct evidence for each comparison.